Stockchase Opinions

Samuel D. IsalyOSI Pharmaceuticals Inc.OSIPTOP PICKAug 13, 2004

Has a low market cap. Have a drug that extends life in lung cancer which should be approved around the turn of the year.
$53.71

Stock price when the opinion was issued

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.